Medical Devices Startups

Arcoma develops high-end radiology and X-ray imaging systems, integrating detectors and imaging software through partnerships with technology providers such as Canon Medical Systems and Varex. The Swedish company sells its products through a global network of distributors across Europe, Asia, and North America.

1 investor

Arcoris Bio develops multiplex biomarker detection technology for researchers and clinicians in biomedical research and diagnostics. The company's MUSE technology enables precise, sensitive detection of multiple biomarkers across fields including cancer, immunology, neuroscience, and pharmaceutical research.

1 investor

AFX Medical develops artificial intelligence software for cancer treatment management and clinical decision support integrated into medical devices for healthcare providers. The company serves oncology clinics and hospitals seeking to improve patient outcomes through AI-augmented diagnostic and treatment tools.

1 investor

Arcturis provides research-ready, regulatory-grade real-world health data and analytics for clinical research and drug development, leveraging a UK-based network of enriched electronic health records and multi-modal patient data. The company generates real-world evidence insights to support clinical trials, external control arms, and health technology assessments.

1 investor

Arcutis is a biopharmaceutical company focused on dermatology, developing treatments for immune-mediated skin diseases such as plaque psoriasis, atopic dermatitis, seborrheic dermatitis, and scalp psoriasis. It serves patients and healthcare professionals with therapies aimed at improving drug efficacy, safety, and tolerability.

1 investor

Arda Therapeutics is a drug development company that uses single-cell computational biology to identify and eliminate pathogenic cells as a way to treat chronic diseases. It operates in the biotechnology and therapeutics sector.

1 investor

ARIA develops a head-worn assistive device for blind and vision-impaired users, combining augmented reality audio, novel control interfaces, and AI-powered sensor systems. The company is led by blind subject matter experts and is pursuing regulatory approval as a Class 2a TGA and FDA Class 1 device.

1 investor

Ark Biosciences is a biopharmaceutical company developing small molecule drugs for infectious diseases, respiratory conditions, neuropsychiatric disorders, and rare diseases. The company has multiple drug candidates in clinical development, with products licensed from partners including Roche and others.

1 investor

Ark Surgical develops tissue containment systems for minimally invasive gynecological procedures. The company's flagship product is designed to enable safe surgical outcomes in women's health by reducing reliance on open abdominal surgery.

1 investor

Arkstone develops AI-powered clinical decision support tools to guide healthcare providers in appropriate antibiotic prescribing and antimicrobial stewardship, reducing unnecessary antibiotic use and antimicrobial resistance. The company serves laboratory professionals, infectious disease specialists, and healthcare systems worldwide.

1 investor

ARNA Genomics US develops liquid biopsy multiomics diagnostic technologies, with a current focus on ARNA Breast, an assay for early-stage breast cancer detection. The company operates as a research diagnostic laboratory conducting clinical trials on its cancer marker tests.

1 investor

Aroa Biosurgery Limited manufactures medical devices, including Endoform, for surgical applications with coverage under Medicare reimbursement policies.

1 investor

AROMICS develops functional genomics and proteomics technologies for research and development of new therapies and diagnostic products in human health. The company focuses on translational research, personalized medicine, and biomarker identification for the pharmaceutical and diagnostics industries.

1 investor

Arpi develops AI-based ECG analysis software for clinical use, providing arrhythmia classification and cardiovascular biomarker risk scores from a single electrocardiogram. Its tools are aimed at clinicians in emergency, clinic, and outpatient settings to detect cardiac risks such as STEMI, hyperkalemia, and left ventricular dysfunction.

1 investor

Arrivo Bio develops novel, disease-modifying medicines targeting the root cause of hard-to-treat diseases for which few effective treatment options exist. The company partners with Mayo Clinic and Daiichi Sankyo to advance first-of-its-kind therapies.

1 investor

Advanced Reconstructive Surgery Alliance (ARSA) is a physician practice management organization (MSO) that provides business support—including compliance, credentialing, finance, HR, IT, marketing, M&A, revenue cycle management, and research—to reconstructive and cosmetic surgery practices. It operates a national network of more than 80 physicians across multiple U.S. states under a "PrivAdemic" model combining private practice with academic collaboration.

1 investor

ArtesRx is a behavioral health long-term care pharmacy organization that operates a network of community-based pharmacies serving patients with complex medication needs, particularly those managing mental illness and substance use disorders.

1 investor

Arthrosi Therapeutics is a clinical-stage biopharmaceutical company developing treatments for gout, an inflammatory arthritis condition. Its lead molecule, AR882, is a urate-lowering agent aimed at reducing uric acid, tophi, and gout flares.

1 investor

Articulus Surgical develops minimally invasive surgical robotic systems designed for India's Tier 2 and Tier 3 hospitals, where infrastructure and space are constrained. The company builds patient and surgeon-centric robotic platforms optimized for resource-limited surgical environments.

1 investor

Artidis develops nanomechanical imaging technology for rapid cancer diagnosis and treatment optimization in clinical settings. The company's diagnostic platform aims to help clinicians with faster, more accurate cancer assessment and prognosis.

1 investor

ArtiFex Medical develops vascular grafts made from bacterial cellulose for small-diameter vascular access. The company provides a biocompatible material solution for vascular applications in the medical device sector.

1 investor

Artivila is an AI-driven pharmaceutical research and development company that uses artificial intelligence and computational chemistry to accelerate drug discovery across oncology, autoimmune diseases, and neurodegenerative diseases. The platform combines AI target identification, lead compound design, and clinical candidate selection to develop novel therapeutics for unmet patient needs.

1 investor

Asahi Surgical Robotics develops and manufactures surgical support robotic systems for medical facilities. The company focuses on improving quality of life for patients, families, and healthcare professionals through medical device innovation.

1 investor

Ascelia Pharma is a biotech company developing and commercializing drugs for rare, orphan oncology-related conditions with unmet medical needs. Its clinical-stage pipeline includes Orviglance, an oral MRI contrast agent for detecting liver lesions, and Oncoral, an oral chemotherapy tablet for gastric cancer.

1 investor